Ultragenyx Pharmaceutical (RARE) FCF Margin Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | -2,544.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,544.00 |
| Dec 31, 2025 | 14.00 |
| Sep 30, 2025 | -568.00 |
| Jun 30, 2025 | -1,490.00 |
| Mar 31, 2025 | 5,628.00 |
| Dec 31, 2024 | -782.00 |
| Sep 30, 2024 | 10,526.00 |
| Jun 30, 2024 | 5,232.00 |
| Mar 31, 2024 | -1,124.00 |
| Dec 31, 2023 | 4,457.00 |
| Sep 30, 2023 | -5,528.00 |
| Jun 30, 2023 | -1,991.00 |
| Mar 31, 2023 | 1,284.00 |
| Dec 31, 2022 | -61.00 |
| Sep 30, 2022 | -403.00 |
| Jun 30, 2022 | 1,372.00 |
| Mar 31, 2022 | -119.00 |
| Dec 31, 2021 | 778.00 |
| Sep 30, 2021 | -1,754.00 |
| Jun 30, 2021 | -23,316.00 |
| Mar 31, 2021 | 12,405.00 |
| Dec 31, 2020 | 14,251.00 |
| Sep 30, 2020 | 28,185.00 |
| Jun 30, 2020 | 52,544.00 |
| Mar 31, 2020 | 24,300.00 |
| Dec 31, 2019 | 11,610.00 |
| Sep 30, 2019 | 23,414.00 |
| Jun 30, 2019 | 21,490.00 |
| Mar 31, 2019 | 29,861.00 |
| Dec 31, 2018 | 347,438.00 |
| Sep 30, 2018 | 3.12 Mn |
| Dec 31, 2017 | 76.23 Mn |
| Sep 30, 2017 | -323,131.00 |